微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -1.34% | -339.29% | -185.11% | 108/132 | 0.36% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -0.47% | -634.09% | -188.68% | 102/132 | 1.85% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.53% | 0% | -19.7% | 87/132 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 0.66% | 1251.83% | 17.86% | 92/132 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.56% | 14.29% | 536.36% | 99/132 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.09% | -56% | -83.4% | 99/132 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.53% | 112% | 1024.96% | 86/132 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -0.06% | 45.89% | -111.69% | 103/132 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 0.49% | 133.79% | 145% | 105/132 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.2% | 112.35% | -20% | 108/132 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.25% | -24.24% | 336.07% | 102/132 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | -0.11% | -118.58% | 92.7% | 109/132 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | -1.45% | -158.47% | 10.49% | 110/132 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | -1.62% | -170.43% | -590.91% | 116/132 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.33% | -80.92% | -42.11% | 98/132 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 0.57% | -91.08% | -77.02% | 118/132 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 2.48% | -45.73% | 7.83% | 98/132 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 2.3% | -30.72% | 32.95% | 104/132 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.73% | 5.49% | -72.93% | 81/132 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 6.39% | 214.78% | 39.82% | 102/132 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 4.57% | 86.53% | 37.65% | 70/132 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 3.32% | 62.75% | 102.44% | 83/132 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.64% | 27.13% | -19.21% | 49/132 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 2.03% | -18.8% | -17.14% | 103/132 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 2.45% | -45.07% | 20.1% | 57/132 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 2.04% | -48.09% | 58.14% | 60/132 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.29% | -46.25% | -48.4% | 39/132 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 2.5% | -71.3% | -43.95% | 92/132 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.46% | -43.47% | 13.49% | 44/132 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 3.93% | -22.64% | 63.75% | 36/132 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 2.4% | -19.19% | -72.45% | 25/132 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 8.71% | 34% | 10.39% | 70/132 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 7.89% | -3.78% | 55.31% | 26/132 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 5.08% | -9.12% | 71.04% | 33/132 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.97% | 0% | -54.31% | 17/132 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 6.5% | -32.57% | -20.73% | 63/132 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 8.2% | -0.24% | 46.69% | 17/132 | 8.69% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 5.59% | 13.39% | 88.22% | 24/132 | 6.26% | 明德生物 | 23.29% | 行业排名> |
| 2016-03-31 | 2.97% | 18.33% | -69.19% | 12/132 | 2.14% | 健帆生物 | 7.75% | 行业排名> |
| 2015-12-31 | 9.64% | 20.65% | 17.27% | 45/132 | 15.95% | 大博医疗 | 55.39% | 行业排名> |
| 2015-09-30 | 8.22% | 22.32% | 66.73% | 16/132 | 7.79% | 鱼跃医疗 | 17.33% | 行业排名> |
| 2015-06-30 | 4.93% | 26.41% | 96.41% | 27/132 | 7.77% | 明德生物 | 29.93% | 行业排名> |
| 2015-03-31 | 2.51% | 51.2% | -68.59% | 18/132 | 3.2% | 中源协和 | 14.44% | 行业排名> |